Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)

12 Months Ended

Dec. 31, 2022

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue

The Company's revenues by segment and primary payor source were as follows:

	Year ended December 31, 2022
	U.S. dialysis		Other - Ancillary services		Consolidated
Patient service revenues:
Medicare and Medicare Advantage	$	6,041,496			$	6,041,496
Medicaid and Managed Medicaid	759,579				759,579
Other government	336,991		464,921		801,912
Commercial	3,437,306		223,216		3,660,522
Other revenues:
Medicare and Medicare Advantage			345,340		345,340
Medicaid and Managed Medicaid			1,546		1,546
Commercial			22,211		22,211
Other(1)	24,437		44,092		68,529
Eliminations of intersegment revenues	(87,035)		(4,206)		(91,241)
Total	$	10,512,774	$	1,097,120	$	11,609,894

    

(1)Other consists primarily of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. IKC and other ancillary services and international operations.

	Year ended December 31, 2021
	U.S. dialysis		Other - Ancillary services		Consolidated
Patient service revenues:
Medicare and Medicare Advantage	$	6,133,235	$		$	6,133,235
Medicaid and Managed Medicaid	782,430				782,430
Other government	328,256		463,385		791,641
Commercial	3,397,697		199,024		3,596,721
Other revenues:
Medicare and Medicare Advantage			326,696		326,696
Medicaid and Managed Medicaid			1,321		1,321
Commercial			15,553		15,553
Other(1)	25,345		40,945		66,290
Eliminations of intersegment revenues	(90,796)		(4,294)		(95,090)
Total	$	10,576,167	$	1,042,630	$	11,618,797

(1)Other consists primarily of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. IKC and other ancillary services and international operations.

	Year ended December 31, 2020
	U.S. dialysis		Other - Ancillary services		Consolidated
Patient service revenues:
Medicare and Medicare Advantage(1)	$	6,169,226	$		$	6,169,226
Medicaid and Managed Medicaid	744,862				744,862
Other government(1)	334,714		380,584		715,298
Commercial	3,370,562		170,394		3,540,956
Other revenues:
Medicare and Medicare Advantage			419,662		419,662
Medicaid and Managed Medicaid			1,227		1,227
Commercial			33,246		33,246
Other(2)	40,571		47,585		88,156
Eliminations of intersegment revenues	(145,286)		(16,743)		(162,029)
Total	$	10,514,649	$	1,035,955	$	11,550,604

(1)During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December 31, 2020 has also been recast to conform to this presentation.

(2)Other consists primarily of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. IKC and other ancillary services and international operations.